EMA — authorised 26 August 2010
- Status: approved
🇪🇺 Vpriv in European Union
EMA authorised Vpriv on 26 August 2010
Marketing authorisation
Vpriv in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Vpriv approved in European Union?
Yes. EMA authorised it on 26 August 2010.
Who is the marketing authorisation holder for Vpriv in European Union?
Shire Human Genetic is the originator. The local marketing authorisation holder may differ — check the official source linked above.